5-bromo-4-chloro-3-indolyl beta-galactoside has been researched along with Neurodegenerative Diseases in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anderson, SR; Baxter, D; Carlson, G; Ebeling, C; Gunn, TM; Hood, LE; Jaques, B; LaPierre, S; Lee, I; Moon, TM; Schweitzer, KM; Silvius, D; Stephenson, DA; Wegner, M | 1 |
1 other study(ies) available for 5-bromo-4-chloro-3-indolyl beta-galactoside and Neurodegenerative Diseases
Article | Year |
---|---|
Disrupted SOX10 function causes spongiform neurodegeneration in gray tremor mice.
Topics: Animals; Biosynthetic Pathways; DNA Mutational Analysis; DNA Primers; Galactosides; Gene Expression Profiling; Gene Expression Regulation; Humans; Indoles; Mice; Mice, Knockout; Mice, Mutant Strains; Microsatellite Repeats; Mutation, Missense; Myelin Sheath; Neurodegenerative Diseases; SOXE Transcription Factors | 2015 |